Why Ophthalmology Assessments Are Non-Negotiable

Ophthalmology assessments play a pivotal role in clinical trials, offering vital insights into participant health and influencing trial outcomes across diverse medical domains. Jessica McKenzie Mays of 20/20 Onsite highlights the diagnostic efficacy of eye exams, yet their integration into trials often encounters obstacles like resource intensiveness, limited patient accessibility, financial burdens, and regulatory hurdles. Addressing these challenges involves leveraging advanced technologies, deploying mobile clinics to enhance patient reach, optimizing financial and logistical frameworks, and adhering to standardized regulatory protocols.
20/20 Onsite provides a comprehensive guide to streamline these assessments, equipping research sites with strategies to navigate potential barriers and enhance the success of clinical trials. This approach not only ensures thorough monitoring of participant health but also fosters the generation of reliable, impactful clinical trial data.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.